Virtus LifeSci Biotech Products ETF Rating $60.15 +0.15 (+0.25%) As of 01/17/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.74Holdings in BBP have an aggregate rating of Moderate Buy based on 674 analyst ratings issued in the past year covering 49 companies (81.3% of the portfolio).BBP Aggregate Price Target$60.15High Prediction$60.15Average Prediction$60.15Low Prediction$60.15Holdings in BBP have an aggregate price target of $60.15 and a range of $60.15 to $60.15 covering 49 companies (81.3% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.52%ITCIIntra-Cellular Therapies$126.200.0%3.8117 of 5 stars2.67$100.31 -20.5%152.05%BBIOBridgeBio Pharma$33.79-0.9%4.0908 of 5 stars2.86$48.08 42.3%14Short Interest ↑2.05%SAGESage Therapeutics$7.08+1.6%4.6129 of 5 stars2.00$10.53 48.7%202.01%HRMYHarmony Biosciences$39.05+1.3%4.5889 of 5 stars3.00$55.00 40.8%8Analyst Revision1.93%HALOHalozyme Therapeutics$54.80-1.0%4.6489 of 5 stars2.60$60.89 11.1%10Short Interest ↑1.87%BPMCBlueprint Medicines$110.05+5.9%1.8727 of 5 stars2.65$122.72 11.5%20Short Interest ↑1.86%NBIXNeurocrine Biosciences$143.26+0.9%4.9027 of 5 stars2.83$164.81 15.0%231.80%MIRMMirum Pharmaceuticals$46.95+2.4%3.9555 of 5 stars3.09$57.10 21.6%111.77%IRWDIronwood Pharmaceuticals$3.66-3.2%4.3432 of 5 stars2.50$10.40 184.2%61.73%EXELExelixis$36.20-1.0%4.7228 of 5 stars2.53$35.50 -1.9%191.72%TVTXTravere Therapeutics$18.37-0.5%2.8635 of 5 stars2.92$24.00 30.6%13Analyst Revision1.70%INCYIncyte$71.93-0.7%4.7767 of 5 stars2.35$76.29 6.1%201.69%ACADACADIA Pharmaceuticals$17.57+0.3%4.0096 of 5 stars2.59$25.25 43.7%171.69%ALNYAlnylam Pharmaceuticals$246.27-1.2%4.4422 of 5 stars2.72$298.61 21.3%251.69%UTHRUnited Therapeutics$358.93-2.0%4.9206 of 5 stars2.73$378.36 5.4%15Positive News1.68%ASNDAscendis Pharma A/S$128.13-2.7%3.6296 of 5 stars2.93$192.07 49.9%14Short Interest ↓Analyst Revision1.68%INSMInsmed$72.51-0.3%3.1334 of 5 stars3.00$83.67 15.4%161.66%IBRXImmunityBio$2.94-3.3%2.4239 of 5 stars3.00$13.58 362.0%4Short Interest ↑Gap UpHigh Trading Volume1.66%GILDGilead Sciences$91.84+0.2%4.4699 of 5 stars2.70$97.96 6.7%27Analyst RevisionPositive News1.65%AXSMAxsome Therapeutics$91.93-1.9%4.675 of 5 stars3.00$130.69 42.2%13Analyst ForecastAnalyst Revision1.64%AMGNAmgen$272.11+1.0%4.8818 of 5 stars2.44$314.91 15.7%27Positive NewsGap Up1.64%ARDXArdelyx$5.01-2.9%3.7537 of 5 stars2.75$9.25 84.6%81.63%LGNDLigand Pharmaceuticals$111.89+0.7%4.9596 of 5 stars3.00$147.00 31.4%61.63%RYTMRhythm Pharmaceuticals$54.54-0.2%4.2187 of 5 stars2.91$68.09 24.8%111.61%DAWNDay One Biopharmaceuticals$12.54+1.1%1.821 of 5 stars3.00$35.86 185.9%91.60%IMCRImmunocore$29.02-0.3%2.4721 of 5 stars2.54$65.64 126.2%131.59%DVAXDynavax Technologies$12.45+0.5%4.5392 of 5 stars2.67$23.00 84.7%31.58%TGTXTG Therapeutics$29.55+1.4%4.5539 of 5 stars2.83$40.67 37.6%61.58%ZLABZai Lab$26.05+2.6%2.5271 of 5 stars3.00$55.00 111.1%31.57%NVAXNovavax$8.40-1.5%4.0183 of 5 stars2.33$17.83 112.3%61.56%REGNRegeneron Pharmaceuticals$681.58-1.7%4.5972 of 5 stars2.65$1,015.38 49.0%231.56%SRPTSarepta Therapeutics$118.00+0.8%4.961 of 5 stars2.91$178.71 51.5%221.55%BNTXBioNTech$111.93-0.7%2.735 of 5 stars2.88$142.72 27.5%17Short Interest ↑1.55%BCRXBioCryst Pharmaceuticals$7.45+5.5%4.2653 of 5 stars2.83$15.17 103.6%6Short Interest ↓High Trading Volume1.54%BMRNBioMarin Pharmaceutical$61.53+0.5%4.9986 of 5 stars2.74$94.20 53.1%23High Trading Volume1.53%FOLDAmicus Therapeutics$9.41+0.5%4.3834 of 5 stars2.78$16.88 79.3%9Analyst Revision1.53%ROIVRoivant Sciences$11.15+2.4%3.653 of 5 stars2.88$17.93 60.8%81.53%SWTXSpringWorks Therapeutics$34.63-2.7%1.5243 of 5 stars3.00$70.00 102.1%61.53%TARSTarsus Pharmaceuticals$46.52-0.9%1.8232 of 5 stars3.00$54.20 16.5%61.52%KNSAKiniksa Pharmaceuticals$18.54+0.8%2.9392 of 5 stars3.00$36.60 97.4%51.51%PTCTPTC Therapeutics$43.84+1.8%4.4128 of 5 stars2.47$55.00 25.5%15High Trading Volume1.51%BIIBBiogen$140.55-0.5%4.7118 of 5 stars2.43$230.00 63.6%281.51%APLSApellis Pharmaceuticals$29.93+0.7%4.4756 of 5 stars2.63$46.65 55.9%19Short Interest ↑Gap Up1.50%MDGLMadrigal Pharmaceuticals$293.64+7.6%4.5425 of 5 stars2.69$351.67 19.8%13High Trading Volume1.49%VRTXVertex Pharmaceuticals$422.00+1.2%4.2848 of 5 stars2.52$490.38 16.2%311.48%ADMAADMA Biologics$16.02-3.7%4.0492 of 5 stars3.25$21.25 32.6%4Short Interest ↑Positive NewsGap Down1.48%CRSPCRISPR Therapeutics$40.53+0.6%2.6816 of 5 stars2.47$78.38 93.4%19Short Interest ↑1.47%ESPREsperion Therapeutics$2.21-2.2%3.4158 of 5 stars2.40$7.30 230.3%5Gap Down1.47%LEGNLegend Biotech$32.66+3.9%2.5869 of 5 stars3.00$80.62 146.8%13Short Interest ↓ This page (NYSEARCA:BBP) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBP Stock Alerts